tht
biomaterials
gmbh

"We literally give drug development, tissue engineering and regenerative medicine a more human touch." 

Johannes Hackethal
CTO, THT Biomaterials GmbH

THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices leading to false positive or negative results. A new visionary platform technology is under development that will speed up research as it makes its results more realistic by replacing animal components with human components.